Screener Summaries Updates Institutions Sign In More Updates › Other Events › GILD Other Events · May 4, 2026
Gilead Sciences held its 2026 annual meeting of stockholders on April 30, resulting in the election of nine directors… GILD Gilead Sciences, Inc.
Gilead Sciences held its 2026 annual meeting of stockholders on April 30, resulting in the election of nine directors and the ratification of Ernst & Young LLP as the company's independent auditor. Shareholders also approved executive compensation and the amended 2022 Equity Incentive Plan, but rejected several stockholder proposals regarding board leadership and ESG/DEI reporting.
More from Gilead Sciences, Inc. Gilead reports Q3 sales of $8.3B and raises full-year revenue guidance by $1.6B Oct 29, 2026 Gilead Sciences reported second quarter 2026 total revenues of $7.8 billion, a 10% increase year-over-year, driven by… Aug 4, 2026 Gilead Sciences has entered into an agreement to issue $3 billion in aggregate principal amount of senior notes to… May 20, 2026 Gilead Sciences announced its financial results for the quarter ended March 31, 2026 May 7, 2026 Gilead Sciences completed its acquisition of Arcellx, Inc. on April 28, 2026, for an aggregate transaction value of… Apr 28, 2026 All content on this site is for informational purposes only and does not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. Always consult a qualified financial advisor before making investment decisions.
Financial data is obtained from public filings and third-party providers and is provided “as-is” without any guarantee of accuracy, completeness, or timeliness.
© 2026 go-intrinsic.com. All rights reserved.
